120 related articles for article (PubMed ID: 12472095)
1. Vigabatrin and visual field disorders.
Prescrire Int; 2002 Dec; 11(62):182. PubMed ID: 12472095
[No Abstract] [Full Text] [Related]
2. Visual field constriction on vigabatrin.
Prescrire Int; 2000 Feb; 9(45):210-1. PubMed ID: 11503799
[TBL] [Abstract][Full Text] [Related]
3. Vigabatrin and epilepsy: further lessons in early childhood.
Parisi P; Bombardieri R; Curatolo P
Epilepsia; 2008 Jan; 49(1):177-8. PubMed ID: 18184225
[No Abstract] [Full Text] [Related]
4. [Influence of vigabatrin on visual fields and electrophysiological tests in patients with epilepsy].
Mrugacz M; Bakunowicz-Łazarczyk A
Klin Oczna; 2003; 105(5):326-8. PubMed ID: 14746191
[TBL] [Abstract][Full Text] [Related]
5. [Changes in visual field of a child treatment with vigabatrin for 2 years].
Mrugacz M; Bakunowicz-Łazarczyk A
Klin Oczna; 2003; 105(5):313-4. PubMed ID: 14746187
[TBL] [Abstract][Full Text] [Related]
6. [Visual field disturbances in epileptic patients treated with vigabatrin (sevril)].
Gross-Tsur V; Lahat E; Banin E; Shahar E; Shalev R
Harefuah; 2002 Mar; 141(3):247-9, 315. PubMed ID: 11944216
[TBL] [Abstract][Full Text] [Related]
7. [Constriction of the visual field by vigabatrin].
Asensio Sánchez VM
An Med Interna; 2002 Dec; 19(12):655-6. PubMed ID: 12593042
[No Abstract] [Full Text] [Related]
8. Delayed, rapid visual field loss in a patient after ten years of vigabatrin therapy.
Clayton LM; Duncan JS; Sisodiya SM; Acheson JF
Eye (Lond); 2010 Jan; 24(1):185-6. PubMed ID: 19373265
[No Abstract] [Full Text] [Related]
9. Is visual field constriction in epilepsy patients treated with vigabatrin reversible?
Schmidt T; Rüther K; Jokiel B; Pfeiffer S; Tiel-Wilck K; Schmitz B
J Neurol; 2002 Aug; 249(8):1066-71. PubMed ID: 12195456
[TBL] [Abstract][Full Text] [Related]
10. Visual field severity indices demonstrate dose-dependent visual loss from vigabatrin therapy.
Conway M; Cubbidge RP; Hosking SL
Epilepsia; 2008 Jan; 49(1):108-16. PubMed ID: 18184224
[TBL] [Abstract][Full Text] [Related]
11. Visual field defect associated with vigabatrin. Many more patients may be affected than were found in study.
Comaish IF; Gorman C; Galloway NR
BMJ; 2000 May; 320(7246):1403; author reply 1404. PubMed ID: 10858054
[No Abstract] [Full Text] [Related]
12. [Vigabatrin and visual fields defects].
Jensen K
Ugeskr Laeger; 2001 Jan; 163(2):184. PubMed ID: 11379251
[No Abstract] [Full Text] [Related]
13. Visual field loss in young children and mentally handicapped adolescents receiving vigabatrin.
Werth R; Schädler G
Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):3028-35. PubMed ID: 16799049
[TBL] [Abstract][Full Text] [Related]
14. [Visual field changes secondary to vigabatrin treatment].
Mauri-Llerda JA; Iñiguez C; Tejero-Juste C; Santos-Lasaosa S; Escalza-Cortina I; Ascaso-Puyuelo J; Abad-Alegría F; Morales-Asín F
Rev Neurol; 2000 Dec 16-31; 31(12):1104-8. PubMed ID: 11205539
[TBL] [Abstract][Full Text] [Related]
15. Visual field defect associated with vigabatrin. Method of estimating prevalence was inappropriate.
Manuchehri K
BMJ; 2000 May; 320(7246):1403-4; author reply 1404. PubMed ID: 10858055
[No Abstract] [Full Text] [Related]
16. Are vigabatrin-associated visual field constrictions asymptomatic?
Schmidt T; Rüther K; Schmitz B
J Neurol; 2004 Jul; 251(7):887-8. PubMed ID: 15258797
[No Abstract] [Full Text] [Related]
17. [Vigabatrin and visual field defects. A Danish material with evaluation of different screening methods].
Riise P; Fledelius HC; Rogvi-Hansen Bà
Ugeskr Laeger; 2003 Mar; 165(10):1034-8. PubMed ID: 12645411
[TBL] [Abstract][Full Text] [Related]
18. [Epilepsy and Sabril].
Depasse F
Bull Soc Belge Ophtalmol; 2007; (304):33-40. PubMed ID: 17718226
[TBL] [Abstract][Full Text] [Related]
19. Visual field defect associated with vigabatrin. Means of selecting patients was misleading.
Midelfart A
BMJ; 2000 May; 320(7246):1404. PubMed ID: 10858056
[No Abstract] [Full Text] [Related]
20. The natural history of Vigabatrin-associated visual field defects in patients electing to continue their medication.
Kumar N; Jivan S
Eye (Lond); 2006 Sep; 20(9):1082-3; author reply 1083-4. PubMed ID: 16244645
[No Abstract] [Full Text] [Related]
[Next] [New Search]
